Laminar Pharmaceuticals
PrivateLast Round
VC Round
Nov 13, 2024
Total Funding Raised
$21.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Laminar Pharmaceuticals is a biopharmaceutical company that specializes in the discovery, rational design, and clinical development of drugs based on Membrane Lipid Therapy (MLT) to treat oncological, neurodegenerative, metabolic, and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laminar Pharmaceuticals Comparables
Compare Laminar Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MimiVax Inc. | 77% | |
| Kazia Therapeutics | 77% | |
| Orbus Therapeutics | 76% |
Laminar Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 13, 2024 | ||||
| Crowdfunding | Nov 19, 2020 | ||||
| Grant | Dec 1, 2017 |
Key People
Founding team and executive leadership
Laminar Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ok Ventures | Series A |
| Keiretsu Forum | Crowdfunding |
| Grupo Empresas Matutes | VC Round |
| Fundación Alba Pérez | VC Round |
| Fellow Funders | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 106% MoM.
- Apr 6, 2026
Monthly visitors increased 56% MoM.
Laminar Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Laminar Pharmaceuticals's valuation, stock price, and market status.
Is Laminar Pharmaceuticals a public or private company?
Laminar Pharmaceuticals is a private company.
What is the current stock price of Laminar Pharmaceuticals?
Laminar Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Laminar Pharmaceuticals worth (valuation)?
Valuation information for Laminar Pharmaceuticals is not publicly available.
Can I buy Laminar Pharmaceuticals stock?
Laminar Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Laminar Pharmaceuticals's last funding round?
Laminar Pharmaceuticals's most recent funding round was VC Round on November 13, 2024.
Who are the main investors in Laminar Pharmaceuticals?
Key investors in Laminar Pharmaceuticals include Ok Ventures, Keiretsu Forum, Grupo Empresas Matutes, Fundación Alba Pérez, Fellow Funders.
Will Laminar Pharmaceuticals IPO soon?
No public IPO plans have been announced for Laminar Pharmaceuticals.
How can I track Laminar Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Laminar Pharmaceuticals's secondary market activity and sign up for updates.